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ABSTRACT 
Background: The appetite-regulating effects of non-digestible carbohydrates (NDC) have in 
part previously been attributed to their effects on intestinal transit rates as well as microbia l 
production of short chain fatty acids (SCFA). Increased colonic production of the SCFA 
propionate has been shown to reduce energy intake and stimulate gut hormone secretion acutely 
in humans.  
Objective: We investigated the effect of the propiogenic NDC, L-rhamnose, on gastrointest ina l 
transit times using a combined 13CO2/H2 breath test. We hypothesised that L-rhamnose would 
increase plasma propionate leading to a reduction in appetite, independent of changes in 
gastrointestinal transit times. 
Design: We used a dual 13C-octanoic acid/lactose 13C-ureide breath test combined with breath 
H2 to measure intestinal transit times following the consumption of 25g/d L-rhamnose, 
compared with inulin and cellulose, in 10 healthy humans in a randomised cross-over design 
pilot study. Gastric emptying (GE) and oro-caecal transit times (OCTT) were derived from the 
breath 13C data and compared with breath H2. Plasma SCFA and peptide YY (PYY) were also 
measured alongside subjective measures of appetite.  
Results: L-rhamnose significantly slowed GE rates (by 19.5min) but there was no difference 
in OCTT between treatments. However, breath H2 indicated fermentation of L-rhamnose 
before it reached the caecum. OCTT was highly correlated with breath H2 for inulin but not for 
L-rhamnose or cellulose. L-rhamnose consumption significantly increased plasma propionate 
and PYY but did not significantly reduce subjective appetite measures.  
Conclusions: The NDCs tested had a minimal effect on intestinal transit time. Our data suggest 
that L-rhamnose is partially fermented in the small intestine and that breath H2 reflects the site 
of gastrointestinal fermentation and is only a reliable marker of OCTT for certain NDCs (e.g. 
inulin). Future studies should focus on investigating the appetite-suppressing potential of L-
rhamnose and verifying the findings in a larger cohort. 
Clinical trial registry no.ISRCTN9022576. 
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INTRODUCTION 
Epidemiological evidence suggests that non-digestible carbohydrates (NDC) play a key role in 
body weight management (1-3). A number of underlying mechanisms have been suggested for 
this effect including the promotion of satiety, increased intraluminal viscosity, delayed 
absorption of nutrients and divergent effects on small and large intestinal transit times 
following NDC consumption (4). In addition, it has been suggested that the production of short 
chain fatty acids (SCFA) via the microbial fermentation of NDC may play a role in mediating 
their appetite suppressing effects. Increasing the colonic production of the SCFA propionate 
has been reported to significantly increase postprandial concentrations of the anorexigenic gut 
hormones peptide YY (PYY) and glucagon- like peptide-1 (GLP-1), and to reduce ad libitum 
energy intake acutely in humans (5). The identification of naturally propiogenic NDCs (i.e. 
NDC that lead to increased relative propionate production following their consumption) that 
successfully suppress appetite is therefore an attractive research avenue.  
L-rhamnose, a non-absorbable monosaccharide, has previously been reported to be propiogenic 
(6, 7). It is not actively absorbed in the small intestine and reaches the colon intact where it is 
fermented by a limited microbial community (8). Inulin, a fructo-oligosaccharide, is an NDC 
that resists enzymatic digestion in the small intestine and is delivered to the large intestine 
intact (9). Dietary supplementation with inulin has been shown to significantly increase caecal 
production of SCFA compared with cellulose in rodents (10) and been associated with a 
reduction in energy intake in humans, albeit at very high doses (>35 g/d) (11). It is however 
currently unknown how L-rhamnose compares to inulin in terms of its propionate-produc ing 
and appetite-suppressing capacity. In contrast, cellulose is often used as a reference fibre due 
to its low and incomplete fermentability by the human gut microbiota (12). We were interested 
to dissect the role of these NDCs on intestinal transit and SCFA production in relation to 
appetite regulation. 
In the present study, we examined whether alterations in intestinal transit time or SCFA 
production profiles were associated with measures of appetite in healthy humans. We used a 
dual 13C octanoic acid / lactose ureide breath test (13, 14), both of which have been validated 
against scintigraphy (13, 15), combined with breath H2, which is routinely used as a measure 
of OCTT for some NDCs (14), to measure GE and OCTT rates following the consumption of 
L-rhamnose. We hypothesised that L-rhamnose would significantly increase circulat ing 
propionate concentrations and would have a similar intestinal transit rate compared with inulin 
(positive control) and cellulose (negative control).  
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SUBJECTS AND METHODS 
This study was carried out in accordance with the Declaration of Helsinki and was approved 
by the London-Harrow Research Ethics Committee (REC) (REC Reference Number 
14/LO/0704). All subjects provided informed, written consent.  
This pilot study was a randomised, double-blind, cross-over trial involving three study visits. 
The primary outcome measure was intestinal transit time and secondary outcome measures 
were plasma SCFA and PYY profiles and finally appetite scores. This was a pilot study because 
prior data on the effects of L-rhamnose on intestinal transit times was not available to undertake 
a sample-size calculation. 
Participant recruitment 
Participants were recruited via existing volunteer databases and poster advertisements. Healthy 
men and women aged between 18-65 years with BMI (kg/m2) 20-35 were eligible for inclus ion. 
Exclusion criteria included the following: weight gain or loss ≥5% body weight in the 
preceding two months, current smokers, substance abuse, excess alcohol intake, any chronic 
illness or gastrointestinal disorder, pregnancy, or use of antibiotics and medications likely to 
interfere with energy metabolism. Eligible participants were randomised into the study by the 
sealed envelope randomisation service (www.sealedenvelope.com). 
Dietary supplements 
L-rhamnose (Carbosynth Limited, Compton, UK) was the interventional supplement used in 
this study. A dose of 25 g/d was chosen as L-rhamnose has previously been shown to increase 
serum propionate at this dosage (6, 7). Inulin (Beneo HP, DKSH, London, UK) was used as a 
positive control (25 g/d). Inulin contains a range of fructose polymers with an average chain 
length of 23. Cellulose (ACI Group Ltd, Slough, UK) was used as a negative control (25 g/d). 
Lactose-[13C] ureide and unlabelled lactose ureide were synthesised at the University of 
Glasgow as previously described (16).  
Study day protocol  
Participants were asked to avoid caffeine, alcohol and strenuous exercise, and to record their 
food intake for the 24 hours before each study visit. Participants consumed the same evening 
meal before each visit in order to promote consistency between visits. Participants were also 
asked to consume 1 g unlabelled lactose ureide 12-24 hours before their visit. This induced 
microbial activity to rapidly hydrolyse lactose-[13C] ureide, leading to a more definitive rise in 
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breath 13CO2 from fermentation (14). Finally, participants were asked to arrive having fasted 
for 12 hours prior to their study visit. 
Study visits were conducted between January and May 2015 in the National Institute for Health 
Research (NIHR)/Wellcome Trust Imperial Clinical Research Facility (CRF), Hammersmith 
Hospital, London, United Kingdom. All participants attended three separate study visits ≥7 
days apart. An overview of the study visit protocol is given in Figure 1. 
 
 
Figure 1: Study visit overview. Overview of timings of blood sampling, VAS ratings and 
breath tests. Abbreviations: H2, hydrogen; VAS, visual analogue scale.  
 
Prior to the consumption of the test meal (0 min), body composition was assessed by 
bioelectrical impedance analysis (Tanita BC-418 analyser; Tanita Corporation, Japan). 
Participants were asked to empty their bladders and change into a set of hospital scrubs prior 
to the collection of body composition data, in order to promote consistency between visits. In 
addition, a number of baseline samples were collected in duplicate (>10 min apart) prior to 
breakfast. Baseline blood samples were collected via a peripheral cannula in order to assess 
circulating SCFA concentrations. Baseline breath H2 measurements were collected in real- time 
using a handheld breath H2 meter (EC60 Gastrolyser Breath Hydrogen Monitor; Bedfont 
Scientific). Baseline breath samples were collected in order to measure 13CO2 natural 
abundance and involved blowing through a straw into an Exetainer (Labco Co., High 
Wycombe, UK) until vapour condensed at the bottom of the tube. Baseline subjective feelings 
of appetite (‘how hungry/full do you feel?’) and mood (‘how nauseous do you feel?’) were also 
collected using a series of 100 mm VAS. The left extremity of the visual analogue scale (VAS) 
was labelled with ‘not at all’ and the right-hand extremity was labelled with ‘extremely’. 
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Participants were asked to draw a vertical line on the VAS depending on how intensely they 
were experiencing each feeling. 
Participants received a standardised breakfast (~470 kcal; Supplementary Table 1) at 0 min 
consisting of 100 mg (1-13C)-Octanoic acid (Sercon Ltd, Crew, UK) and 500 mg lactose-[13C] 
ureide and 25 g L-rhamnose, inulin or cellulose, according to the participant’s randomisat ion. 
Participants were provided with a standardised snack (~650 kcal) at 180 min and a standardised 
meal (~550 kcal) at 360 min (Supplementary Table 1). Further venous blood and breath 
samples were collected and VAS were completed throughout the study visit (Figure 1). After 
480 min, the cannula was removed and participants were discharged from the CRF. 
Finally, participants were asked to collect breath samples hourly for 4 hours following 
discharge and to collect a breath sample as soon as they woke up on the morning after their 
study visit in order to keep tracking breath 13CO2 enrichment. In addition to this, participants 
were asked to consume the same evening meal after each visit to promote consistency between 
visits. 
Blood sample preparation 
5 ml venous blood samples were collected in plain 5 ml glass tubes and kept on ice until 
centrifugation. Samples were centrifuged at 2,500 relative centrifugal force (RCF) at 4°C for 
10 min. Resulting plasma was aliquoted into cryovials and immediately frozen at -80°C until 
assaying for SCFA and PYY.  
Breath sample analysis 
Breath samples were analysed by isotope ratio mass spectrometry (IRMS) (17), a method used 
for measuring the relative abundance of isotopes in any given sample, as previously described 
(14).  
Curve-fitting of breath 13CO2 data 
The fraction of tracer recovered in breath per hour (PDR/h) was calculated using Microsoft 
Excel software using the following equation: 
𝑃𝐷𝑅 ℎ⁄ = [𝑉𝐶𝑂2 .𝑏𝑟𝑒𝑎𝑡ℎ 
13𝐶 𝑒𝑛𝑟𝑖𝑐ℎ𝑚𝑒𝑛𝑡
(
𝑚𝑔 𝑑𝑜𝑠𝑒
𝑀𝑊 ) . 𝑑𝑜𝑠𝑒 𝑒𝑛𝑟𝑖𝑐ℎ𝑚𝑒𝑛𝑡. 𝑛
⁄ ] . 100   
Where VCO2 is the CO2 production rate (estimated to be 300 mmol/m2 body surface/h; (18), 
with body surface estimated according to Haycock et al. (19)), breath 13C enrichment is the 13C 
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enrichment of breath over baseline (ppm excess), mg dose is the amount of substrate 
administered (mg), MW is the molecular weight of substrate, dose enrichment is the 13C 
enrichment of substrate (ppm 13C), and n is the number of isotopically labelled atoms in the 
substrate molecule. 
Breath data were analysed using a modified version of the curve-fitting techniques developed 
by Ghoos et al. (13) and Maes et al. (20), as previously published (14).  
𝑌 =  𝑎1(𝑡 –  𝑑1)
𝑏1. 𝑒𝑥𝑝(−𝑐1(𝑡−𝑑1))  +  𝑎2(𝑡 –  𝑑2)
𝑏2. 𝑒𝑥𝑝(−𝑐2(𝑡−𝑑2)) 
The variables ai, bi, ci and di each describe a facet of each peak(i1, i2) in the breath test data; a 
is the scaling factor related to the amplitude of the peak, b relates to the ascending slope, c 
relates to the downslope of the peak and d was introduced to facilitate the fitting of multip le 
peaks, as previously described (14). The function was fitted to the data using Microsoft Excel 
software. The non-linear regression Solver function was used to minimise the difference (root 
mean square, RMS) between the fitted curve and the raw data by adjusting the variables a, b, c 
and d for both curves simultaneously (21). 
Two parameters defined from the fitted curve were used to describe the gastric emptying (GE) 
rate; t1/2 and tmax, Both have previously been shown to significantly correlate with scintigraphy 
data, supporting their use as measures of GE (20). t1/2 is defined as the timepoint at which 50% 
of exhaled 13CO2 is recovered under the GE curve. tmax is defined as the time from substrate 
ingestion to the time of maximal breath enrichment. Both t1/2 and tmax were calculated as 
previously described (20) with the minor modification off adding the value of d1 to each value 
to account for any delay in GE. The ‘d’ term for the OCTT curve, d2, was calculated as a 
measure of OCTT. It was defined as the time at which breath 13CO2 excretion, from the 
modelled data (peak 2) was non-zero and was arbitrarily set at 0.01 – the time when breath 
13CO2 excretion reached 0.01 PDR/hr. This was undertaken using the GOALSEEK function in 
Excel to return the time (t) when the equation describing peak 2 (using the best-fit parameters) 
was equal to 0.01. 
Breath H2 excretion times 
The first sustained rise in breath H2 was determined for each volunteer on each visit and was 
considered a marker of OCTT.  
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Metabolic and hormone analysis 
Thawed samples were vortexed and aliquoted into fresh cryotubes containing heparin sodium 
(2 µl/100 µl sample; 1,000 IU/ml, Wockhardt UK Ltd.). Plasma PYY was measured using a 
previously established in-house specific and sensitive radioimmunoassay (22, 23). Plasma 
SCFA were measured using an Agilent 7000C Triple Quadrupole GC/MS System according 
to a previously published method (24). Data processing was performed using Agilent 
MassHunter Quantitative Analysis software and SCFA concentrations were integrated from a 
freshly prepared calibration curve.  
Composite appetite score 
A composite appetite score (CAS) was calculated from the VAS as previously described using 
the following formula (25):  
𝐶𝐴𝑆 =  
[𝐻𝑢𝑛𝑔𝑒𝑟 +  (100 – 𝐹𝑢𝑙𝑙𝑛𝑒𝑠𝑠)  +  𝐷𝑒𝑠𝑖𝑟𝑒 𝑡𝑜 𝐸𝑎𝑡 +  𝐴𝑝𝑝𝑒𝑡𝑖𝑡𝑒 𝑓𝑜𝑟 𝑀𝑒𝑎𝑙] 
4
 
Statistics 
Data were checked for normality (defined as P≥0.01) using the Shapiro-Wilk test. Results are 
presented as means ± standard error of the mean (SEM) or medians [Interquartile Range; IQR] 
if non-parametric. Missing VAS, breath H2 and PYY data points were replaced with the mean 
group value at that timepoint. The average of two separate baseline measurements for breath 
H2, CAS, plasma SCFA and plasma PYY data, which were collected before breakfast, were 
used for the 0 min measurement. Baseline values were compared using a one-way analysis of 
variance (ANOVA). If baseline values were significantly different between groups, results are 
presented as percentage change from baseline. Area under the curve (AUC) and area over the 
curve (AOC) were calculated using the trapezoidal rule. AUC/AOC and breath data were 
compared using a one-way repeated measures ANOVA with post hoc Fischer LSD test. If non-
parametric, data were compared using a Friedman’s test with post-hoc Wilcoxon signed rank 
tests. Postprandial SCFA and PYY concentrations were compared with baseline concentrations 
using paired t-tests or Wilcoxon’s signed rank tests. R2 was calculated using linear regression. 
Significance was considered P<0.05. Statistical analysis was performed using IBM SPSS 
Statistics v23-v24. Graphs were prepared using GraphPad Prism v5.0-7.0.  
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RESULTS 
Participants  
Participant characteristics are given in Table 1. Ten healthy men and women participated in 
this study.  
Table 1: Participant characteristics 
 Variable Participants 
Male n (%) 4 (40%) 
European Caucasian n (%) 10 (100%) 
Age (y) 58.9 ± 1.9 
Weight (kg) 70.9 ± 1.9 
BMI (kg/m2) 24.8 ± 0.7 
Body fat (%) 28.2 ± 2.6 
1 Values are means ± SEMs or n (%).  
Anthropometric data are means of all three study visit measurements. 
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Breath 13C enrichment profiles and intestinal transit times 
The profiles of breath 13CO2 recovery and breath H2 concentrations following the dual 13C 
breath test and the consumption of cellulose, inulin and L-rhamnose are shown in Figure 2.  
 
Figure 2: Breath H2 concentrations and breath 13C enrichment profiles following a dual 
13C breath test and the consumption of L-rhamnose, inulin or cellulose. Each graph 
displays mean ± SEM (purple solid line) 13CO2 recovery (PDR h-1; left y axis), determined by 
IRMS analysis, (green dashed line) GE rates and (blue dashed line) OCTT (PDR h-1; left axis), 
determined by a two-peak GE and colonic fermentation model, and (solid orange line) breath 
H2 concentrations (ppm; right y axis) following the consumption of 100 mg (1-13C)-Octanoic 
acid and 500 mg lactose-[13C] ureide and (A) cellulose, (B) inulin or (C) L-rhamnose at 0 min 
(n=10). Abbreviations: GE, gastric emptying; IRMS, isotope ratio mass spectrometry; OCTT, 
orocaecal transit time; PDR, percentage dose recovery.  
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A two-peak model was fitted to the data and used to determine GE and OCTT; individual data 
and group means are given in Figure 3 and Table 2, respectively. 
 
 
Figure 3: Parameters of gastric emptying and orocaecal transit time following 
consumption of L-rhamnose, inulin or cellulose. Data represents parameters of GE rate (A) 
t1/2 and (B) tmax, and parameters of OCTT (C) d2, and (D) H2 excretion time (n=10). Each data 
point represents one participant. t1/2, tmax and d2 were determined from the modelled 13C data 
in order to describe the GE rate and OCTT; t1/2 was defined as the timepoint at which 50% of 
exhaled 13CO2 is recovered, tmax was defined as the time from substrate ingestion to the time of 
maximal breath enrichment and d2 was defined as the time at which breath 13CO2 excretion was 
non-zero. The H2 excretion time was defined as the time at which there was the first sustained 
rise in breath H2 and was measured in real time using a breath H2 monitor. Abbreviations: GE, 
gastric emptying; IRMS, isotope ratio mass spectrometry; OCTT, orocaecal transit time.  
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Table 2: Parameters of gastric emptying and orocaecal transit time following consumption of 
L-rhamnose, inulin or cellulose 
Breath Test Parameter Cellulose (h) Inulin (h) L-rhamnose (h) P-value 5 
GE rate   
  
t1/2 1 3.4 ± 0.2a 3.4 ± 0.1b 3.7 ± 0.1a,b 0.020 
tmax2 2.6 ± 0.1a 2.7 ± 0.1b 3.1 ± 0.1a,b 0.017 
OCTT     
d2 3 4.4 ± 0.4 3.7 ± 0.4 4.4 ± 0.2 0.21 
H2 excretion time 4 6.5 [6.5, 7.0]a,b 3.5 [2.5, 4.0]b,c 1.5 [1.0, 2.0]a,b <0.001 
 
Parametric data are expressed as means ± SEMs and non-parametric data are expressed as 
median [IQR] (n=10). Units are in h. Abbreviations: GE, gastric emptying; NDC, non-
digestible carbohydrate; OCTT, orocaecal transit time. 
1,2,3 Parameters were determined from the modelled 13C data in order to describe the GE rate 
and OCTT 
1 t1/2 was defined as the timepoint at which 50% of exhaled 13CO2 is recovered.  
2 Tmax was defined as the time from substrate ingestion to the time of maximal breath 
enrichment and was calculated using the following equation Tmax = (b/c) + d 
3 d2, a measure of OCTT, was defined as the time at which breath 13CO2 excretion, from the 
modelled data (peak 2) was non-zero and was arbitrarily set at 0.01 – the time when breath 
13CO2 excretion reached 0.01 PDR/hr. This was undertaken using the GOALSEEK function in 
Excel to return the time (t) when the equation describing peak 2 (and using the best-fit 
parameters) was equal to 0.01. 
4 H2 excretion time was defined as the time at which there was the first sustained rise in breath 
H2 concentrations. 
5 Parametric data were compared using a one-way repeated measures ANOVA with post-hoc 
Fischer LSD test. Non-parametric data were compared using a Friedman’s test with post-hoc 
Wilcoxon Signed Ranks Test. 
a,b,c indicate significant differences in post-hoc tests  
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There was a small but significant difference for GE rate (t1/2) between groups (P=0.020; Table 
2). Post-hoc tests revealed that the t1/2 was longer for L-rhamnose compared with cellulose 
(effect size: mean ± SEM; 0.35 ± 0.13 h, P=0.023) and inulin (0.30 ± 0.11 h, P=0.023), which 
suggests that L-rhamnose delayed GE by 19.5 minutes on average. Similarly, there was a 
significant difference in the tmax parameter for GE rate between groups (P=0.017).  Post-hoc 
analysis revealed that the tmax for L-rhamnose was longer compared with cellulose (0.45 ± 0.16 
h, P=0.018) and inulin (0.34 ± 0.11 h, P=0.012), which also supports the observation that L-
rhamnose delayed GE versus cellulose and inulin. 
There was no significant difference between groups for the ‘d’ term parameter calculated to 
describe OCTT (d2, P=0.21). However, there was a significant difference in H2 excretion times 
between groups (P<0.001). Post-hoc tests revealed there was a shorter time to sustained H2 
excretion time for L-rhamnose (P=0.004) and inulin (P=0.005) compared with cellulose, 
suggesting a shorter OCTT for L-rhamnose and inulin as determined by H2 excretion. L-
rhamnose also had a shorter time to sustained H2 excretion time compared with inulin 
suggesting a shorter OCTT (P=0.005). 
There was no significant difference in t1/2, tmax, OCTT (d2) or breath H2 excretion times between 
visits independent of the NDC consumed (P=0.34-P=0.90). 
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Correlation between OCTT as assessed by 13CO2 and H2 excretion 
The correlations between 13CO2 and H2 excretion times following consumption of cellulose, 
inulin or L-rhamnose are shown in Figure 4. As previously described by Schneider et al. (26), 
13CO2 from lactose-[13C] ureide fermentation significantly correlated with the H2 excretion 
times following the consumption of inulin (r2=0.89, P<0.001; Figure 4). However, for both 
cellulose and L-rhamnose 13CO2 data there was no significant correlation with the H2 excretion 
times (P=0.63 and 0.77, respectively). 
 
Figure 4: Correlation between orocaecal transit times as assessed by 13CO2 and H2 
excretion. Correlation between OCTT (h) as measured using the 13CO2 and H2 excretion times 
for (A) cellulose, (B) inulin and (C) L-rhamnose (n=10). OCTT was defined as the time at 
which breath 13CO2 excretion, from the modelled data (peak 2) was non-zero or as the time at 
which there was the first sustained rise in breath H2 concentrations, respectively. R2 was 
calculated using linear regression. Abbreviations: OCTT13CO2, orocaecal transit time assessed 
with lactose-[13C] ureide breath test; OCTTH2, orocaecal transit time assessed with H2 breath 
test.  
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Plasma SCFA 
There was no difference in the baseline concentrations of any SCFA between groups (P=0.32-
0.60). There was a difference in the AUC0-480 for propionate between treatments (P<0.001; 
Figure 5D). Post-hoc analysis revealed that AUC0-480 for propionate was significantly greater 
for L-rhamnose than cellulose (effect size: 1.36 ± 0.15 μM x min, P<0.001) and inulin (effect 
size: 1.41 ± 0.13 μM x min, P<0.001) confirming increased propionate production from L-
rhamnose. There was also a difference in the AUC0-480 for acetate between treatments (P<0.001; 
Figure 5B). Post-hoc analysis revealed that the AUC0-480 for acetate was significantly greater 
for L-rhamnose than cellulose (effect size: 20.39 ± 3.73 μM x min, P<0.001) and inulin (effect 
size: 9.95 ± 3.69 μM x min, P=0.025), suggesting increased acetate production from L-
rhamnose. In addition, the AUC0-480 for acetate following consumption of inulin was 
significantly larger than cellulose (effect size: 10.44 ± 2.36 μM x min, P=0.002). There was no 
significant difference in the AUC0-480 for butyrate between treatments (P=0.59; Figure 5F).  
Following the consumption of L-rhamnose, there was a trend for propionate concentrations 
(Figure 5C) to be higher than baseline at 120 min (effect size: 0.67 ± 0.30, P=0.052) and 
concentrations were significantly higher than baseline at 240 (effect size: 2.41 ± 0.42, P<0.001) 
and 360 min (effect size: 0.99 ± 0.36, P=0.023). There was no difference in propionate 
concentrations at 480 min versus baseline (effect size: 0.75 ± 0.56, P=0.21). Interestingly, 
despite the greater AUC0-480 following consumption of L-rhamnose versus cellulose and inulin, 
postprandial concentrations of acetate were not significantly higher than baseline at any 
timepoint measured (P=0.31-0.81; Figure 5A).  
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Figure 5: Plasma short chain fatty acid concentrations following consumption of L-
rhamnose, inulin or cellulose. Data represents (A) mean ± SEM acetate (C) median (IQR) 
propionate and (E) median (IQR) butyrate over time and mean ± SEM (B) AUC0-480 for acetate, 
(D) AUC0-480 for propionate and (F) AUC0-480 for butyrate following ingestion of cellulose, 
inulin or L-rhamnose at 0 min (n=10). Standardised meals were provided at 180 and 360 min. 
AUCs were compared using a one-way ANOVA. *P<0.05, **P<0.01, ***P<0.005. 
Abbreviations: AUC, area under the curve. 
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Plasma PYY 
While the measurement of plasma PYY concentrations was not an a priori outcome measure, 
the significant increase in circulating propionate concentrations observed following the 
consumption of L-rhamnose prompted us to measure plasma PYY. There was no difference in 
the plasma PYY concentrations between groups at baseline (P=0.47; Figure 6). There was a 
significant difference in the AUC0-480 for PYY between treatments (P=0.001; Figure 6B). Post-
hoc analysis revealed that the AUC0-480 for PYY was significantly larger for L-rhamnose than 
cellulose (effect size: 9.77 ± 4.0 pmol/L x min, P=0.037) and inulin (effect size: 16.41 ± 4.16 
pmol/L x min, P=0.003), suggesting higher concentrations following the consumption of L-
rhamnose. PYY concentrations were significantly higher than baseline at all postprandial 
timepoints measured; 60 min (effect size: 14.11 ± 4.88 pmol/L, P=0.018), 180 min (effect size: 
24.31 ± 8.22 pmol/L, P=0.016), 300 min (effect size: 31.04 ± 7.32 pmol/L, P=0.002) and 420 
min (effect size: 28.38 ± 9.70 pmol/L; P=0.017). 
 
Figure 6: Plasma PYY concentrations following consumption of L-rhamnose, inulin or 
cellulose. Data represents (A) median (IQR) plasma PYY over time and (B)  mean ± SEM 
AUC0-420 PYY, following ingestion of or cellulose, inulin or L-rhamnose at 0 min (n=10). 
Standardised meals were provided at 180 and 360 min. AUCs were compared using a one-way 
ANOVA. *P<0.05, **P<0.01. Abbreviations: AUC, area under the curve. 
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Composite appetite score 
There was a significant difference in CAS between groups at baseline (P=0.006). This was due 
to participants reporting significantly lower CAS at baseline of the L-rhamnose visit compared 
with cellulose (effect size: 5.6 ± 2.3 mm, P=0.033) and inulin (effect size: 9.7 ± 3.2 mm, 
P=0.015). Therefore data are expressed as percentage change from baseline (Figure 7). There 
was no difference between treatments for CAS area over the curve (AOC)0-480 (P=0.37).  
 
Figure 7: Percentage change from baseline in composite appetite score visual analogue  
scales following consumption of L-rhamnose, inulin or cellulose. Data represents mean ± 
SEM (A) percentage change from baseline in composite appetite score over time, and (B) 
AOC0-480 for the percentage change from baseline in composite appetite score following 
ingestion of cellulose, inulin or L-rhamnose at 0 min (n=10). Percentage change from baseline 
(0 min) was calculated using the following equation [(postprandial CAS – baseline 
CAS)/baseline CAS)*100]. Standardised meals were provided at 180 and 360 min. 
Abbreviations: AOC, area over the curve; CAS, composite appetite score. 
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DISCUSSION 
A dual 13C breath test combined with breath H2 excretion was used in this pilot study in order 
to evaluate effects on gut transit of three different NDC; cellulose, inulin and L-rhamnose. The 
aim of conducting this study was two-fold: 1) to ascertain if variations in transit time could 
explain an observed effect on appetite; 2) to examine the variability in the optimum time-
window for assessment of appetite where SCFA production from NDC is maximal and most 
likely to have an impact on satiety for future studies.  
L-rhamnose significantly delayed GE when compared with cellulose and inulin (t1/2: by 21 and 
18 min, respectively). While the caloric load and nutritional composition of a meal are 
understood to affect GE rates (27), these factors are unlikely to have caused the differences 
observed in this study as the test meals were provided at exactly the same time in each group,  
were isoenergetic and had the same nutritional composition. Alternatively, the rate of GE has 
previously been shown to be strongly influenced by the osmolality of the contents of the 
duodenum, with increased osmolality slowing GE (28, 29). Therefore, L-rhamnose may have 
resulted in a delay in GE versus inulin and cellulose due to its greater osmotic load. However, 
it is currently unknown whether the modest reduction in GE rate observed following the 
consumption of L-rhamnose would have a significant impact on eating behaviour. 
Despite detecting differences in GE rates between the NDC there were no differences in OCTT 
as measured from breath 13C excretion. However, in contrast, breath H2 excretion times suggest 
a significantly shorter transit time for L-rhamnose and inulin versus cellulose, and a 
significantly shorter transit time for L-rhamnose versus inulin. This difference in gut transit 
times as assessed using breath H2 and 13CO2 was an unexpected finding and not in line with 
the original hypothesis. The H2-based inulin breath test has previously been used in multip le 
research studies as a reliable measure of OCTT and has been shown by Schneider et al. to 
correlate well with the lactose-[13C] ureide breath test data following the consumption of inulin 
(26). Similarly, in the present study, transit time determined from the breath H2 excretion times 
significantly correlated with the 13C data following the consumption of inulin thus validat ing 
our data modelling approach and confirming fermentation of inulin in the caecum. However, 
for both cellulose and L-rhamnose the 13C data does not correlate with the H2 excretion data. It 
is possible that differences in the sites of fermentation of these substrates may explain the 
findings. Despite the perception that L-rhamnose reaches the colon intact (7), the early rise in 
breath H2 in the present study occurs before the stomach has fully emptied and before L-
rhamnose has reached the caecum according to the 13C data suggesting that L-rhamnose is 
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being partially fermented in the small intestine. In support of this hypothesis, Boojink et al. 
reported the presence of species related to Ruminococcus obeum in the ileal effluent of humans 
(30), which has previously been shown to ferment L-rhamnose via the propanediol pathway 
leading to the production of propionate (8). In contrast to L-rhamnose and inulin, cellulose is 
thought to have low or incomplete fermentability (12). However, in the present study there was 
a small but sustained rise in breath H2 from 6 h following the consumption of cellulose, 
consistent with observations from previous studies (31), and suggests that cellulose is 
fermented more distally in the colon compared with inulin (32). There was also a similar later 
rise in breath H2 following consumption L-rhamnose, which corresponds with the 13C data and 
appears to represent fermentation of L-rhamnose in the colon. Together, the presented data 
suggest there was no difference in OCTT for the three NDCs tested but a difference in the 
fermentability and the site of fermentation within the intestine of the substrates. Furthermore, 
these data suggest that breath H2 is only a suitable measure of OCTT following the consumption 
of certain NDCs (e.g. inulin) and its use as a marker of OCTT is unreliable following 
consumption of some NDCs (e.g. L-rhamnose and cellulose). Therefore, it is proposed that 
breath H2 should only be used as a reliable marker of fermentability and not OCTT unless 
independent verification of the site of fermentation can be established.  
Plasma propionate concentrations were significantly higher following consumption of L-
rhamnose versus inulin and cellulose, which supports the hypothesis that L-rhamnose is 
propiogenic (6, 7). Plasma propionate concentrations were elevated above baseline from 120-
360 min (P=0.023). This early increase in plasma propionate is observed following breath H2 
excretion and is detected in the peripheral circulation before L-rhamnose has reached the 
caecum according to the 13C data. Together, these data further support the proposal that L-
rhamnose does not reach the colon intact, as previously suggested, and is partially fermented 
in the small intestine. Interestingly, plasma acetate concentrations were higher following L-
rhamnose compared with inulin, which was unexpected. One possible explanation for this 
increase in acetate could be due to differences in the rate of fermentation of the NDC owing to 
differences in chain length. For example, other short-chain inulin molecules like fructo-
oligosaccharides (FOS) are more rapidly fermented versus long-chain inulin (33), which 
undergoes less rapid fermentation (9).  
The co-expression of the SCFA receptors, free fatty acid receptor (FFAR) 2 and FFAR3, in 
PYY and GLP-1 secreting enteroendocrine cells (EEC) has prompted suggestions that SCFA 
production following the consumption of NDC may stimulate the secretion of these 
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anorexigenic gut hormones (5). In acute studies, increased colonic propionate has previous ly 
been shown to increase plasma PYY and GLP-1 concentrations in humans (5). Therefore, it 
was originally hypothesised that the consumption of L-rhamnose would reduce appetite via an 
increase in colonic propionate production, which would stimulate the secretion of anorexigenic 
gut hormones. Although our data suggests that the increase in plasma propionate concentrations 
following the consumption of L-rhamnose may be due to an increased production of propionate 
in the small intestine as well as in the colon, the propionate data prompted us to measure plasma 
PYY concentrations (34). As hypothesised, the increase in peripheral propionate levels 
observed following consumption of L-rhamnose was associated with a significant increase in 
plasma PYY concentrations versus inulin and cellulose and is the first time to our knowledge 
that L-rhamnose has been shown to increase plasma PYY concentrations. Interestingly, post-
prandial PYY was most elevated after L-rhamnose appeared to arrive in the colon. The increase 
in postprandial PYY concentrations noted in the current study suggests that L-rhamnose could 
influence satiety. However, as appetite was not the primary outcome of this pilot study, the 
only appetite measure collected were VAS. While there was no effect of treatment on the 
composite appetite score, as this study was not adequately powered to measure differences in 
VAS these data should be treated with caution. Interestingly, since the completion of the 
current study, Darzi et al. reported that 25.5 g L-rhamnose does not reduce appetite (35). 
However, ad libitum food intake was measured at 420 min, which is significantly later than the 
peak propionate and PYY concentrations noted in our study (240-300 min), suggesting effects 
on appetite may have been missed and should be addressed in future studies. Finally, a notable 
finding in the current study is the large inter- and intra-individual variability in GI transit times 
as outlined in Figure 3, which others have previously reported (36, 37). While the data from 
the current study are in line with the literature, the variations in gut transit times further 
emphasise the challenges when designing such studies aiming to detect differences in appetite. 
The use of a dual 13C breath test, which has previously been validated against scintigraphy (13, 
15), and a human crossover study design are major strengths of this trial. However, the small 
sample size in this pilot study is a limitation. Future studies are required in order to verify our 
findings in a larger cohort. 
In summary, the presented data suggest that the NDC tested have minimal effects on gut transit 
time. Despite previously being considered to be fermented exclusively in the colon, the 
presented 13C breath data, breath H2 and plasma SCFA data suggest that L-rhamnose also 
undergoes microbial fermentation in the small intestine. Furthermore, our data suggests that 
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breath H2 should only be used as a reliable marker of fermentability and not OCTT unless 
corroborated by an independent measure of OCTT. Finally, despite elevated propionate and 
PYY concentrations following consumption of L-rhamnose in addition to L-rhamnose slowing 
GE rate, L-rhamnose did not suppress subjective feelings of appetite. Further work is needed 
to assess whether these effects would alter eating behaviour.  
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